Skip to main content
Premium Trial:

Request an Annual Quote

CORRECTED: Applied Biosystems Says to Sell Sequencers to deCODE

A story from Wednesday, Sept 13 entitled "Applied Biosystems Sells 200 Sequencers to deCODE" has been corrected after a company spokesman revised the number of machines included in the deal. The spokesman said that he had incorrectly stated that the deal would be for 200 machines. A corrected version follows:

MIAMI, Sept 14 - Genomics instrumentation company Applied Biosystems (NYSE: PEB) said Thursday it had sold a number of its ABI Prism 3700 DNA sequencers to deCODE genetics (Nasdaq: DCGN), however the deal includes fewer machines than originally announced.

On Wednesday a spokesman for Applied Biosystems told GenomeWeb that the company had sold 200 sequencers to deCODE of Iceland. Later the spokesman revised the statement, saying that the deal would be for "about 50" machines.

Applied Biosystems expects to make an annoucement about the deal in the near future.

deCODE plans to use the machines for a massive sequencing project on the Icelandic population, Applied Biosystems said.

deCODE was not immediately available for comment.

deCODE, through its research into the inherited causes of common diseases, seeks to turn raw genomics data into products and services for the healthcare industry.

The list price for the 3700 sequencers is $250,000. Over the past two years, Applied Biosystems has sold about 2,000 of the 3700 units.

Sister company Celera Genomics (NYSE: CRA), the biggest customer of the 3700 with some 300 units, used the machines to help accelerate the sequencing of the human genome.

 

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.